Adalimumab for nail psoriasis: Efficacy and safety from the open-label extension of a phase-3, randomized, placebo-controlled trial

被引：0
|
作者：
Gottlieb, Alice B. [1 ]
Elewski, Boni E. [2 ]
Okun, Martin M. [3 ]
Bagel, Jerry [4 ]
Poulin, Yves [5 ]
Gu, Yihua [6 ]
Williams, David A. [6 ]
Valdecantos, Wendell C. [6 ]
机构：
[1] New York Med Coll, Valhalla, NY 10595 USA
[2] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
[3] Ft Hlth Care, Ft Atkinson, WI USA
[4] Univ Med Ctr Princeton, Plainsboro, NJ USA
[5] Ctr Dermatolog Quebec Metropolitain, Quebec City, PQ, Canada
[6] AbbVie Inc, N Chicago, IL USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2017年 / 76卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
4844
引用
收藏
页码：AB33 / AB33
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of Switching from Adalimumab to Sarilumab in an Open-label Extension of a Phase 3 Monotherapy Trial in Patients with Active Rheumatoid Arthritis
    Burmester, Gerd
    Fiore, Stefano
    Hu, Chih-Chi
    Fay, Jonathan
    Lee, Eun-Bong
    Genovese, Mark
    [J]. JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 1035 - 1035
  • [22] Efficacy and Safety of Switching from Adalimumab to Sarilumab in an Open-Label Extension of a Phase 3 Monotherapy Trial in Patients with Active Rheumatoid Arthritis
    Burmester, Gerd R.
    Fiore, Stefano
    Hu, Chih-Chi
    Fay, Jonathan
    Lee, Eun Bong
    Genovese, Mark C.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [23] Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study
    Lesley M. Arnold
    Kenneth N. Schikler
    Lucinda Bateman
    Tahira Khan
    Lynne Pauer
    Pritha Bhadra-Brown
    Andrew Clair
    Marci L. Chew
    Joseph Scavone
    [J]. Pediatric Rheumatology, 14
  • [24] Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study
    Arnold, Lesley M.
    Schikler, Kenneth N.
    Bateman, Lucinda
    Khan, Tahira
    Pauer, Lynne
    Bhadra-Brown, Pritha
    Clair, Andrew
    Chew, Marci L.
    Scavone, Joseph
    [J]. PEDIATRIC RHEUMATOLOGY, 2016, 14
  • [25] A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase
    Manning, Donald C.
    Gimbel, Joseph
    Wertz, Robert
    Rauck, Richard
    Cooper, Alyse
    Zeldis, Jerome B.
    Levinsky, Dale M.
    [J]. PAIN MEDICINE, 2017, 18 (03) : 477 - 487
  • [26] Efficacy of adalimumab in the treatment of preiradiographic axial spondyloarthritis: Results of a 20-week, randomized controlled trial with an open-label extension phase
    Haibel, H.
    Rudwaleit, M.
    Amtenbrink, A.
    Heldmann, F.
    Listing, J.
    Wong, R.
    Kupper, H.
    Braun, J.
    Sieper, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 64 - 64
  • [27] Efficacy of adalimumab in the treatment of preradiographic axial spondyloarthritis: Results of a 20-week, randomized controlled trial with an open-label extension phase
    Haibel, H.
    Rudwaleit, M.
    Amtenbrink, A.
    Heldmann, F.
    Listing, J.
    Kupper, H.
    Braun, J.
    Sieper, J.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 14 - 14
  • [28] EFFICACY AND SAFETY OF SWITCHING FROM ADALIMUMAB TO SARILUMAB IN AN OPEN-LABEL EXTENSION OF A PHASE 3 MONOTHERAPY TRIAL IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA)
    Burmester, G. R.
    Fiore, S.
    Hu, C-C
    van Hoogstraten, H.
    Lee, Bong E.
    Genovese, M. C.
    [J]. INTERNAL MEDICINE JOURNAL, 2018, 48 : 21 - 21
  • [29] Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial
    Himanshu P. Upadhyaya
    Jenny Y. Chien
    Amanda J. Long
    Martin S. Bohm
    Nicole L. Kallewaard
    Lisa F. Macpherson
    Dipak R. Patel
    Matthew M. Hufford
    Constance J. Krull
    Jocelyn Y. Ang
    Peter Chen
    William J. Muller
    Jeffrey A. Potts
    Timothy Quinn
    Mark Williams
    [J]. Infectious Diseases and Therapy, 2023, 12 : 1861 - 1873
  • [30] Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial
    Upadhyaya, Himanshu
    Chien, Jenny Y.
    Long, Amanda J.
    Bohm, Martin
    Kallewaard, Nicole
    Macpherson, Lisa
    Patel, Dipak
    Hufford, Matthew
    Krull, Constance
    Ang, Jocelyn
    Chen, Peter
    Muller, William
    Potts, Jeffrey
    Quinn, Timothy
    Williams, Mark
    [J]. INFECTIOUS DISEASES AND THERAPY, 2023, 12 (07) : 1861 - 1873
12345